United States - English - NLM (National Library of Medicine)

henry schein animal health - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 1.5 mg in 1 ml - eloxioral oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs. dogs with known hypersensitivity to meloxicam should not receive eloxioral oral suspension. do not use eloxioral oral suspension in cats. acute renal failure and death have been associated with the use of meloxicam in cats.

United States - English - NLM (National Library of Medicine)

butler schein animal health - magnesium hydroxide (unii: nbz3qy004s) (magnesium cation - unii:t6v3lhy838) - magnesium hydroxide 5.83 g - butler schein animal health a henry schein company

United States - English - NLM (National Library of Medicine)

butler animal health supply, llc d/b/a henry schein animal health - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 5 mg in 1 ml - dogs: eloxiject™ (meloxicam) 5 mg/ml solution for injection is indicated in dogs for the control of pain and inflammation associated with osteoarthritis. dogs with known hypersensitivity to meloxicam should not receive eloxiject 5 mg/ml solution for injection. cats: for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery. cats with known hypersensitivity to meloxicam should not receive eloxiject 5 mg/ml solution for injection. additional doses of meloxicam or other nsaids in cats are contraindicated, as no safe dosage for repeated nsaid administration has been established (see animal safety). do not use meloxicam in cats with pre-existing renal dysfunction.

United States - English - NLM (National Library of Medicine)

henry schein inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: conjunctivitis: corneal ulcers: *efficacy for this organism was studied in fewer than 10 infections ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication (see warnings ).

United States - English - NLM (National Library of Medicine)

henry schein inc. - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 5 mg in 1 g - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin. for prophylaxis of ophthalmia neonatorum due to n. gonorrhoeae or c. trachomatis . the effectiveness of erythromycin in the prevention of ophthalmia caused by penicillinase-producing n.gonorrhoeae is not established. for infants born to mothers with clinically apparent gonorrhea, intravenous or intramuscular injections of aqueous crystalline penicillin g should be given; a single dose of 50,000 units for term infants or 20,000 units for infants of low birth weight. topical prophylaxis alone is inadequate for these infants. this drug is contraindicated in patients with a history of hypersensitivity to erythromycin.

United States - English - NLM (National Library of Medicine)

henry schein inc. - tropicamide (unii: n0a3z5xtc6) (tropicamide - unii:n0a3z5xtc6) - for mydriasis and cycloplegia for diagnostic procedures. contraindicated in persons showing hypersensitivity to any component of this preparation.

United States - English - NLM (National Library of Medicine)

henry schein inc. - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk) - tobramycin ophthalmic solution usp, 0.3% is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobramycin ophthalmic solution usp, 0.3%. clinical studies have shown tobramycin to be safe and effective for use in pediatric patients. tobramycin ophthalmic solution usp, 0.3% is contraindicated in patients with known hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

henry schein inc. - proparacaine hydrochloride (unii: u96ol57goy) (proparacaine - unii:b4ob0jhi1x) - proparacaine hydrochloride ophthalmic solution is indicated for topical anesthesia in ophthalmic practice. representative ophthalmic procedures in which the preparation provides good local anesthesia include measurement of intraocular pressure (tonometry), removal of foreign bodies and sutures from the cornea, conjunctival scraping in diagnosis and gonioscopic examination; it is also indicated for use as a topical anesthetic prior to surgical operations such as cataract extraction. this preparation is contraindicated in patients with known hypersensitivity to any component of the solution.

Australia - English - Department of Health (Therapeutic Goods Administration)

henry schein halas - 61049 - instrument/equipment drape, single-use, non-sterile - this non-sterile single use device range is intended to be used as a protective covering for various instruments/equipment thereby providing a barrier against cross-contamination.

Australia - English - Department of Health (Therapeutic Goods Administration)

henry schein halas - 11155 - dental rubber dam, latex - this single use elastomeric dental device, when placed over a tooth/intraorally during a routine dental restorative procedure, helps 1) isolate the field of operation from the rest of the oral cavity; 2) eliminate saliva; 3) prevent the patient swallowing liquid/dental material; 4) protect soft tissue from harmful solutions; and 5) aids reduce risk of infection.